Topics

Companies Related to "Dietary vulnerability found cancer cells with mutated spliceosomes" [Most Relevant Company Matches] - Page: 20 RSS

04:06 EST 8th December 2019 | BioPortfolio

Here are the most relevant search results for "Dietary vulnerability found cancer cells with mutated spliceosomes" found in our extensive corporate database of over 50,000 company records.

Showing "Dietary vulnerability found cancer cells with mutated spliceosomes" Companies 476–500 of 4,000+

Probably Relevant

Plasticell

Plasticell is a pioneering biotechnology company that specialises in the differentiation of stem cells to obtain cell types for a range of biomedical applications. Founded in 2002, Plasticell has assembled an outstanding team of scientists with longstanding expertise in stem cell research, particularly in directed stem cell differentiation. The company is advised by an eminent Scientific Advisor...


Cancer Trials Australia

Cancer Trials Australia is the leading provider of early phase cancer clinical trials because we aim for excellence in quality, timeliness and cost. We will achieve our vision by sustaining a collaborative culture, protecting our outstanding reputation, and actively encouraging innovation.Cancer Trials Australia is a not-for-profit service organisation that operates with the highest standards of e...

TRACON Pharmaceuticals, Inc.

TRACON Pharmaceuticals is a privately held biotechnology company focused on the development of products for oncology and ophthalmology treatment, including agents that inhibit angiogenesis. TRACON addresses unmet needs in these areas with first-in-class product candidates that will complement existing therapies. TRC093 is a monoclonal antibody that binds to cleaved collagen to inhibit angiogenesis...


Marshall Edwards

Marshall Edwards, Inc. ('MEI') is a pharmaceutical company dedicated to the field of cancer therapy (oncology).MEI is developing a range of anti-cancer therapies that represents the next generation of oncology drugs - multiple signal transduction regulators (abbreviated as 'MSTRs') that reach to the heart of the cancer process.The source of this new range of drugs is a family of chemicals, discove...

Cyclacel Pharmaceuticals

Cyclacel Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to the discovery, development and commercialization of novel, mechanism-targeted drugs to treat human cancers and other serious disorders. Our science, management and expertise in cell cycle biology are the core of our business strategy. We have a deep pipeline that includes: seliciclib (CYC202) and sapacitabine (CYC682), in c...

Accent Therapeutics

Accent Therapeutics is a biopharmaceutical company developing oncology-focused, small molecule therapies in the emerging field of epitranscriptomics. This field of biology encompasses post-transcriptional chemical modifications of RNA that provide cells with a unique mechanism for regulating proteins critical for cellular growth and differentiation. By tar...

Pershing Square Sohn Cancer Research Alliance

The Pershing Square Sohn Cancer Research Alliance was formed in 2013 through a $25 million commitment by Bill and Karen Ackman and The Pershing Square Foundation, which partnered with The Sohn Conference Foundation. The Alliance is dedicated to playing a catalytic role in accelerating cures for cancer by supporting innovative cancer research and by facilit...

Kadimastem

Kadimastem (www.kadimastem.com) is a biotechnology company focused on the industrial development and commercialization of human pluripotent stem cell-based products. At Kadimastem, the pluripotent stem cell technology is used to produce specialized human cells and tissues for two major types of medical applications: 1) Drug-screening platforms using human ...

Teen Cancer America

Every hour another 13-25 year old is diagnosed with cancer in America. Teen Cancer America transforms the lives for this under-served patient population by working with our country’s leading cancer treatment and research centers. They create specialized clinical care programs, offer therapeutic experiences and provide access to individualized support and ...

John Theurer Cancer Center

The John Theurer Cancer Center at Hackensack University Medical Center is New Jersey's largest and most comprehensive center dedicated to the diagnosis, treatment, management, research, screenings, and preventive care as well as survivorship of patients with all types of cancer. The 15 specialized divisions covering the complete spectrum of cancer care have developed a close-knit team of medical, ...

City of Hope

City of Hope is a leading research and treatment center for cancer, diabetes and other life-threatening diseases. Designated as a comprehensive cancer center, the highest recognition bestowed by the National Cancer Institute, City of Hope is also a founding member of the National Comprehensive Cancer Network, with research and treatment protocols that advance care throughout the nation. City of ...

Geron Corporation

Geron is developing first-in-class biopharmaceuticals for the treatment of cancer and chronic degenerative diseases, including spinal cord injury, heart failure and diabetes. The company is advancing an anti-cancer drug and a cancer vaccine that target the enzyme telomerase through multiple clinical trials in different cancers. For more information, visit ...

Abviva, Inc.

Abviva, Inc. is a biomedical company engaged in the innovation, development and commercialization of breast cancer related applications of Mammastatin, a growth inhibitory protein discovered at the University of Michigan Cancer Center that demonstrated anti-breast cancer properties. The discovery was developed into a simple breast cancer diagnostic blood test that demonstrated healthy women have h...

Sandy Rollman Ovarian Cancer Foundation

The Sandy Rollman Ovarian Cancer Foundation, a 501 (c) (3) non-profit, now celebrating its 17th year, was created as a tribute to the life, character, and immense strength of Sandy Rollman. Sandy passed away from advanced ovarian cancer in May 2000. Prior to diagnosis, Sandy experienced many textbook symptoms. Her symptoms were whispering only no on...

GNC

St. Jude Children's Research Hospital is internationally recognized for its pioneering work in finding cures and saving children with cancer and other catastrophic diseases. St. Jude is the first and only pediatric cancer center to be designated as a Comprehensive Cancer Center by the National Cancer Institute. Founded by late entertainer Danny Thomas and based in Memphis, Tenn., St. Jude freely s...

ASCO American Society of Clinical Oncology

The American Society of Clinical Oncology (ASCO) is the world’s leading professional organization representing physicians who care for people with cancer. With more than 30,000 members, ASCO is committed to improving cancer care through scientific meetings, educational programs and peer-reviewed journals. For ASCO information and resources, visit www.asco.or...

US Oncology Foundation

The Life Beyond Cancer Foundation advances cancer care in local communities by removing the barriers to prevention, education, early detection, treatment and survivorship. By working with local nonprofit and community organizations, the foundation helps cancer patients with funding for everyday living expenses and helps to educate the community about cancer prevention and early detection through l...

Genea Stem Cells Pty Ltd

Genea Stem Cells Pty Ltd is a subsidiary of Genea Limited (formerly Sydney IVF Limited), a public, unlisted company that has been operating IVF clinics in Australia since 1985. Genea Stem Cells Pty Ltd is governed by the same strong ethical principles and corporate governance practices. Genea Stem Cells is located in Sydney, Australia and has been supplying commercial stem cell solutions for s...

Blue Ridge Cancer Care

Blue Ridge Cancer Care (BRCC) is an independent private practice of 19 physicians specializing in the diagnosis and treatment of cancer and blood disorders. BRCC’s ten convenient locations throughout the southwest region of Virginia provide comprehensive and cutting-edge cancer care closer to where patients live. BRCC provides a number of services and...

Erimos Technologies, LLC

Erimos has exclusive license for nordihydroguaiaretic acid (NDGA) derivatives from The Johns Hopkins University. We have developed a novel process to extract NDGA from the resin of the leaves of Larrea tridentata, a desert plant indigenous to the southwestern US and Mexico. EM-1421, our lead candidate, is a semi-synthetic derivative of NDGA. It is designed to target specific differences between no...

Salutron Technologies, Inc.

Salutron Technologies, Inc. develops physiological monitoring solutions for wearable devices and exercise equipment. The wearable devices, in band and watch form factors can be found in major retailers under private label brands or under Salutron's SmartHealth brand. Salutron also provide customized heart rate electronics to leading fitness equipment manuf...

Cancer Commons

Cancer Commons is a non‐profit open science initiative dedicated to improving outcomes for today’s cancer patients. Our goals are to: 1) give each patient the best possible outcome by individualizing their treatment based on their tumor’s genomic subtype; 2) learn as much as possible from each patient’s response, and 3) rapidly disseminate wha...

Tower Cancer Research Foundation

Founded in 1996, Tower Cancer Research Foundation is a nonprofit organization committed to providing research, community education, and patient support while developing more effective treatments for cancer and blood disorders. For more information, please call 310-285-7242 or visit www.towercancerfoundation.org.

WellSpring Pharmaceutical Corporation

Important specialty pharmaceutical products are the foundation of our business.While larger pharmaceutical companies are divesting themselves of these unique pharmaceutical products, we recognize their enduring therapeutic value in smaller groups of patients. So we continue to acquire, produce and market a variety of popular, niche products that are used to treat disorders found in neonatology, ca...

The John Theurer Cancer Center at Hackensack University Medical Center

The John Theurer Cancer Center at Hackensack University Medical Center is New Jersey's largest and most comprehensive center dedicated to the diagnosis, treatment, management, research, screenings, and preventive care as well as survivorship of patients with all types of cancer. The 15 specialized divisions covering the complete spectrum of cancer care have developed a close-knit team of medical, ...


More From BioPortfolio on "Dietary vulnerability found cancer cells with mutated spliceosomes"

Quick Search

Corporate Database Quicklinks